-
ITCI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intra-Cellular Therapies (ITCI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 466.06 mm | 466.06 mm | 466.06 mm | 466.06 mm | 466.06 mm | 466.06 mm |
Cash burn (monthly) | 76.33 mm | (no burn) | 12.95 mm | 10.14 mm | 8.84 mm | 5.18 mm |
Cash used (since last report) | 307.01 mm | n/a | 52.08 mm | 40.76 mm | 35.56 mm | 20.83 mm |
Cash remaining | 159.05 mm | n/a | 413.98 mm | 425.30 mm | 430.50 mm | 445.23 mm |
Runway (months of cash) | 2.1 | n/a | 32.0 | 42.0 | 48.7 | 86.0 |
13F holders | Current |
---|---|
Total holders | 347 |
Opened positions | 44 |
Closed positions | 64 |
Increased positions | 132 |
Reduced positions | 122 |
13F shares | Current |
---|---|
Total value | 6.57 tn |
Total shares | 97.29 mm |
Total puts | 143.00 k |
Total calls | 318.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
FMR | 11.12 mm | $813.77 bn |
Vanguard | 9.63 mm | $704.50 bn |
BlackRock | 6.22 mm | $455.05 bn |
JPM JPMorgan Chase & Co. | 5.29 mm | $386.80 bn |
Wasatch Advisors | 3.85 mm | $281.60 bn |
BBBOF BB Biotech | 3.54 mm | $112.52 mm |
Avoro Capital Advisors | 3.05 mm | $223.17 bn |
IVZ Invesco | 2.99 mm | $218.75 bn |
BLVGF Bellevue | 2.49 mm | $181.87 bn |
STT State Street | 1.86 mm | $136.02 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | Riggs Rory B | Common Stock | Grant | Acquire A | No | No | 83.52 | 215 | 17.96 k | 131,512 |
5 Dec 24 | Mates Sharon | Common Stock | Sell | Dispose S | No | Yes | 84.6897 | 1,534 | 129.91 k | 1,070,329 |
5 Dec 24 | Mates Sharon | Common Stock | Sell | Dispose S | No | Yes | 84.0645 | 50,163 | 4.22 mm | 1,071,863 |
5 Dec 24 | Mates Sharon | Common Stock | Option exercise | Acquire M | No | No | 12.73 | 51,697 | 658.10 k | 1,122,026 |
5 Dec 24 | Mates Sharon | Stock Option Common Stock | Option exercise | Dispose M | No | No | 12.73 | 51,697 | 658.10 k | 0 |
4 Dec 24 | Mates Sharon | Common Stock | Sell | Dispose S | No | Yes | 86.0048 | 23,333 | 2.01 mm | 1,070,329 |
4 Dec 24 | Mates Sharon | Common Stock | Sell | Dispose S | No | Yes | 85.6222 | 27,667 | 2.37 mm | 1,093,662 |
4 Dec 24 | Mates Sharon | Common Stock | Option exercise | Acquire M | No | No | 12.73 | 51,000 | 649.23 k | 1,121,329 |
4 Dec 24 | Mates Sharon | Stock Option Common Stock | Option exercise | Dispose M | No | No | 12.73 | 51,000 | 649.23 k | 51,697 |
13 Nov 24 | Michael Halstead | Common Stock | Sell | Dispose S | No | Yes | 88.92 | 5,343 | 475.10 k | 0 |